This page gives details of CPPsite entry with ID 2532 |
Primary information | |
---|---|
CPPsite ID | 2532 |
PEPTIDE SEQUENCE | RRRRRR |
PEPTIDE NAME | V2 |
CHIRALITY | L |
LINEAR/CYCLIC | Linear |
SOURCE | Synthetic |
CATEGORY | Cationic |
SUB CELLULAR LOCALIZATION | Cytoplasm and Nucleus |
N-TERMINAL MODIFICATION | Conjugated to FITC modified folding domain via β-alanine–glycine– glycine linker |
C-TERMINAL MODIFICATION | Amidation |
UPTAKE EFFICIENCY | V2 has a stronger preference to accumulate within the nuclear bodies that contain a high con- centration of DNA |
INVITRO/INVIVO | In vitro |
CELL LINE | NIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells |
CARGO | Peptide (FITC labelled peptide) |
PMID | 25524829 |
PATENT | Unknown |
LENGTH | 6 |
Secondary Structure | CCCCCC |
SMILES | N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C=O |
Tertiary Structure (Technique) | View in Jmol  OR Download Structure (PEPstrMOD) |